{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "2e132b67",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import glob\n",
    "import os\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fdf3b86d",
   "metadata": {},
   "source": [
    "# Data needed "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "77f46ad3",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (6,13,19,23,25,26,27,28,29,30,35,37,38,39,41,43,44,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (23,29,37) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (6,13,14,19,23,25,26,27,28,30,35,38,39,41,43,44,47,48,49,53) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (14) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (4,6,13,19,25,26,27,28,30,35,38,39,42,43,46,47,48) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (23) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (1,6,13,19,25,26,27,28,30,35,38,39,40,41,42,43,46,47,48,49,52) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (4) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (6,13,14,19,23,25,26,27,28,29,30,35,38,39,41,43,44,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (14,23,29) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (4,6,13,19,25,26,27,28,30,35,38,39,40,41,43,44,47,48,49,53) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (6,13,19,23,25,26,27,28,30,35,38,39,42,43,46,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (1,6,13,19,23,25,26,27,28,30,35,38,39,41,43,44,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (1,6,8,13,14,19,23,25,26,27,28,29,30,35,38,39,42,43,46,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (8,14,29) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (5,6,13,19,25,26,27,28,30,35,38,39,41,43,44,47,48,49,50,51,53) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (0,1,4,6,13,19,23,25,26,27,28,30,35,37,38,39,42,43,46,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (37) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (6,13,19,23,25,26,27,28,30,35,38,39,41,43,44,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n",
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/IPython/core/interactiveshell.py:3437: DtypeWarning: Columns (2,6,13,14,19,23,25,26,27,28,29,30,35,38,39,41,43,44,47,48,49) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study_ID</th>\n",
       "      <th>Customer_SampleID</th>\n",
       "      <th>GHRequestID</th>\n",
       "      <th>GHSampleID</th>\n",
       "      <th>Patient_ID</th>\n",
       "      <th>Visit_name</th>\n",
       "      <th>Alt-NoAlt</th>\n",
       "      <th>Sample_status</th>\n",
       "      <th>Sample_comment</th>\n",
       "      <th>Variant_type</th>\n",
       "      <th>...</th>\n",
       "      <th>Cancertype</th>\n",
       "      <th>Practice_name</th>\n",
       "      <th>Physician_name</th>\n",
       "      <th>HRD_score</th>\n",
       "      <th>Amplification_type</th>\n",
       "      <th>Tumor_stage</th>\n",
       "      <th>ctDNA_detected</th>\n",
       "      <th>Somatic_variant_reportable</th>\n",
       "      <th>cfDNA_ng_yield</th>\n",
       "      <th>Alt.NoAlt</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ARX_01</td>\n",
       "      <td>6520333569-26</td>\n",
       "      <td>A0692859</td>\n",
       "      <td>B00323252</td>\n",
       "      <td>006-006</td>\n",
       "      <td>C2D1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SUCCESS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SNV</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ARX_01</td>\n",
       "      <td>6520333569-26</td>\n",
       "      <td>A0692859</td>\n",
       "      <td>B00323252</td>\n",
       "      <td>006-006</td>\n",
       "      <td>C2D1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SUCCESS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SNV</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ARX_01</td>\n",
       "      <td>6520333569-26</td>\n",
       "      <td>A0692859</td>\n",
       "      <td>B00323252</td>\n",
       "      <td>006-006</td>\n",
       "      <td>C2D1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SUCCESS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SNV</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ARX_01</td>\n",
       "      <td>6520333569-26</td>\n",
       "      <td>A0692859</td>\n",
       "      <td>B00323252</td>\n",
       "      <td>006-006</td>\n",
       "      <td>C2D1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SUCCESS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SNV</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ARX_01</td>\n",
       "      <td>6520333569-26</td>\n",
       "      <td>A0692859</td>\n",
       "      <td>B00323252</td>\n",
       "      <td>006-006</td>\n",
       "      <td>C2D1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>SUCCESS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SNV</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 62 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "  Study_ID Customer_SampleID GHRequestID GHSampleID Patient_ID Visit_name  \\\n",
       "0   ARX_01     6520333569-26    A0692859  B00323252    006-006       C2D1   \n",
       "1   ARX_01     6520333569-26    A0692859  B00323252    006-006       C2D1   \n",
       "2   ARX_01     6520333569-26    A0692859  B00323252    006-006       C2D1   \n",
       "3   ARX_01     6520333569-26    A0692859  B00323252    006-006       C2D1   \n",
       "4   ARX_01     6520333569-26    A0692859  B00323252    006-006       C2D1   \n",
       "\n",
       "   Alt-NoAlt Sample_status Sample_comment Variant_type  ... Cancertype  \\\n",
       "0        1.0       SUCCESS            NaN          SNV  ...        NaN   \n",
       "1        1.0       SUCCESS            NaN          SNV  ...        NaN   \n",
       "2        1.0       SUCCESS            NaN          SNV  ...        NaN   \n",
       "3        1.0       SUCCESS            NaN          SNV  ...        NaN   \n",
       "4        1.0       SUCCESS            NaN          SNV  ...        NaN   \n",
       "\n",
       "    Practice_name  Physician_name  HRD_score Amplification_type Tumor_stage  \\\n",
       "0  Not Applicable  Not Applicable        NaN                NaN         NaN   \n",
       "1  Not Applicable  Not Applicable        NaN                NaN         NaN   \n",
       "2  Not Applicable  Not Applicable        NaN                NaN         NaN   \n",
       "3  Not Applicable  Not Applicable        NaN                NaN         NaN   \n",
       "4  Not Applicable  Not Applicable        NaN                NaN         NaN   \n",
       "\n",
       "  ctDNA_detected Somatic_variant_reportable cfDNA_ng_yield  Alt.NoAlt  \n",
       "0            NaN                        NaN            NaN        NaN  \n",
       "1            NaN                        NaN            NaN        NaN  \n",
       "2            NaN                        NaN            NaN        NaN  \n",
       "3            NaN                        NaN            NaN        NaN  \n",
       "4            NaN                        NaN            NaN        NaN  \n",
       "\n",
       "[5 rows x 62 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "direc = '/ghds/pharma/datawarehouse/data/infinity_report_warehouse/'\n",
    "\n",
    "df_all = pd.DataFrame()\n",
    "\n",
    "#substring_list = ['202307', '202308', '202309', '202310', '202306']\n",
    "\n",
    "for file in glob.glob(direc + '*.csv'):\n",
    "    #if not any(substring in file for substring in substring_list):\n",
    "        df_bip = pd.read_csv(file)\n",
    "        if (len(df_bip.columns)>1):\n",
    "         #if ('Sirius-1.1' in df_bip.columns[1]) :\n",
    "            df = pd.read_csv(file, skiprows=1)        \n",
    "            if 'Study_ID' not in df:\n",
    "                df = pd.read_csv(file)\n",
    "                if 'Study_ID' not in df:\n",
    "                    continue\n",
    "            df_all = pd.concat([df_all, df])\n",
    "    \n",
    "df_all.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "2efb7444",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/ghess/pharma/scratch/gyalamanchili/clinical_trial_data_leverage\n"
     ]
    }
   ],
   "source": [
    "!pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "0d4ed2ed",
   "metadata": {},
   "outputs": [],
   "source": [
    "clinical_trial = pd.read_csv('/ghess/pharma/scratch/gyalamanchili/clinical_trial_data_leverage/ctg-studies.csv')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "67000f23",
   "metadata": {},
   "source": [
    "# Analysis "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "353792fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "101863"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(clinical_trial)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "910dde80",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "96"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "study_id_of_interest = list(set(df_all['Study_ID'].dropna().astype(str)))\n",
    "len(study_id_of_interest)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "7f96af6e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "AMG_07\n",
      "GSK-TRACER-2\n",
      "MS201924-0022\n",
      "GSK EMU-019\n",
      "PICI0009\n",
      "IQN_01_V3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/gyalamanchili/anaconda3/envs/jupyterlabsimplefunction2/lib/python3.7/site-packages/ipykernel_launcher.py:6: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "GSK- EMU- 17B\n",
      "201-P2 \n",
      "BOU_02\n",
      "TAK-981 LBx Pilot \n",
      "ARX_01\n",
      "201-2b \n",
      "GSK EMU-SOW16\n",
      "MR_MATRIX\n",
      "mCRPC_BIOBANK\n",
      "TAK-103 LBx Pilot 2023\n",
      "201-P1 C3 \n",
      "TT816-12-001\n",
      "201-P1 C3\n",
      "JCOG1801 A1\n",
      "GSK-EMU-021\n",
      "IB-SASOW12_1\n",
      "OSU_BR\n",
      "459073\n",
      "CGG21-016P\n",
      "ATA188\n",
      "ONO-4578-04\n",
      "METRICS\n",
      "ONO-4578-03\n",
      "OSU_01\n",
      "GSK-EMU-SOW23-2\n",
      "NOPRODLUC002\n",
      "CL003_1\n",
      "GSK-TRACER-3\n",
      "ATA129-201\n",
      "BTBC\n",
      "GHStudy\n",
      "SOW 148\n",
      "GSK-EMU-024\n",
      "GSK-EMU-SOW23-1\n",
      "GSK- EMU- 17A\n",
      "CHIP_MATRIX\n",
      "201-P1 2c\n",
      "201-1 \n",
      "ONO-4578-05\n"
     ]
    }
   ],
   "source": [
    "final_df = pd.DataFrame([])\n",
    "ids_not_detected = []\n",
    "for var in study_id_of_interest:\n",
    "    df_needed = clinical_trial[clinical_trial['Other IDs'].fillna('-').apply(lambda x:var in x)]\n",
    "    if len(df_needed)>0:\n",
    "        df_needed['study_id'] = var\n",
    "        final_df = pd.concat([final_df,df_needed])\n",
    "        continue\n",
    "    else :\n",
    "        ids_not_detected.append(var)\n",
    "        print (var)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2936ce84",
   "metadata": {},
   "source": [
    "# Deep dive on studies we dont detect"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "f58f6dcf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Other IDs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>52993</th>\n",
       "      <td>NCT05975073</td>\n",
       "      <td>A Phase 1/2 Study of AMG 193 in Combination Wi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05975073</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The main aims of this study are to evaluate th...</td>\n",
       "      <td>NO</td>\n",
       "      <td>MTAP-null Non-Small-Cell Lung Cancer|MTAP-null...</td>\n",
       "      <td>DRUG: AMG 193|DRUG: IDE397</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20220127</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72434</th>\n",
       "      <td>NCT05094336</td>\n",
       "      <td>AMG 193, Methylthioadenosine (MTA) Cooperative...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05094336</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The primary objective of Parts 1 and 2 of this...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced MTAP-null Solid Tumors</td>\n",
       "      <td>DRUG: AMG 193|DRUG: Docetaxel|DRUG: Comparator...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20210023</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number                                        Study Title  \\\n",
       "52993  NCT05975073  A Phase 1/2 Study of AMG 193 in Combination Wi...   \n",
       "72434  NCT05094336  AMG 193, Methylthioadenosine (MTA) Cooperative...   \n",
       "\n",
       "                                          Study URL Study Status  \\\n",
       "52993  https://clinicaltrials.gov/study/NCT05975073   RECRUITING   \n",
       "72434  https://clinicaltrials.gov/study/NCT05094336   RECRUITING   \n",
       "\n",
       "                                           Brief Summary Study Results  \\\n",
       "52993  The main aims of this study are to evaluate th...            NO   \n",
       "72434  The primary objective of Parts 1 and 2 of this...            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "52993  MTAP-null Non-Small-Cell Lung Cancer|MTAP-null...   \n",
       "72434                    Advanced MTAP-null Solid Tumors   \n",
       "\n",
       "                                           Interventions Sponsor  \\\n",
       "52993                         DRUG: AMG 193|DRUG: IDE397   Amgen   \n",
       "72434  DRUG: AMG 193|DRUG: Docetaxel|DRUG: Comparator...   Amgen   \n",
       "\n",
       "      Collaborators  Sex                 Age      Study Type Other IDs  \n",
       "52993           NaN  ALL  ADULT, OLDER_ADULT  INTERVENTIONAL  20220127  \n",
       "72434           NaN  ALL  ADULT, OLDER_ADULT  INTERVENTIONAL  20210023  "
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# 'AMG_07' doesnt match with existing studyid, best we can do is print out Study Title, Study URL and NCT Number for a sponser\n",
    "buf = clinical_trial[clinical_trial['Other IDs'].fillna('-').apply(lambda x:'AMG' in x)].copy()#[['Other IDs']]\n",
    "clinical_trial[(clinical_trial.Sponsor.apply(lambda x:'amg' in x.lower())) & (clinical_trial['Brief Summary'].fillna('-').apply(lambda x:'MTAP' in x))]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "9b395a6e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Other IDs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>11540</th>\n",
       "      <td>NCT02980809</td>\n",
       "      <td>Topotecan Plus Apatinib Versus Topotecan Alone...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02980809</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The purpose of this study is to determine whet...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Small Cell Lung Cancer</td>\n",
       "      <td>DRUG: Apatinib|DRUG: Topotecan</td>\n",
       "      <td>First Hospitals affiliated to the China PLA Ge...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>gsk-001</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number                                        Study Title  \\\n",
       "11540  NCT02980809  Topotecan Plus Apatinib Versus Topotecan Alone...   \n",
       "\n",
       "                                          Study URL Study Status  \\\n",
       "11540  https://clinicaltrials.gov/study/NCT02980809      UNKNOWN   \n",
       "\n",
       "                                           Brief Summary Study Results  \\\n",
       "11540  The purpose of this study is to determine whet...            NO   \n",
       "\n",
       "                   Conditions                   Interventions  \\\n",
       "11540  Small Cell Lung Cancer  DRUG: Apatinib|DRUG: Topotecan   \n",
       "\n",
       "                                                 Sponsor Collaborators  Sex  \\\n",
       "11540  First Hospitals affiliated to the China PLA Ge...           NaN  ALL   \n",
       "\n",
       "                      Age      Study Type Other IDs  \n",
       "11540  ADULT, OLDER_ADULT  INTERVENTIONAL   gsk-001  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# 'GSK-TRACER-2' doesnt match with existing studyid, best we can do is print out Study Title, Study URL and NCT Number for a sponser\n",
    "buf = clinical_trial[clinical_trial['Other IDs'].fillna('-').apply(lambda x:'gsk' in x)].copy()#[['Other IDs']]\n",
    "#clinical_trial[(clinical_trial.Sponsor.apply(lambda x:'gsk' in x.lower())) & (clinical_trial['Brief Summary'].fillna('-').apply(lambda x:'MTAP' in x))]\n",
    "buf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "5832b71f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['AMG_07',\n",
       " 'GSK-TRACER-2',\n",
       " 'ONO-4578-01',\n",
       " 'MS201924-0022',\n",
       " 'GSK EMU-019',\n",
       " 'PICI0009',\n",
       " 'RP-3500-03',\n",
       " 'IQN_01_V3',\n",
       " 'ACT16845',\n",
       " 'MK-3475-799',\n",
       " 'GSK- EMU- 17B',\n",
       " '201-P2 ',\n",
       " 'BOU_02',\n",
       " 'TAK-981 LBx Pilot ',\n",
       " 'ARX_01',\n",
       " '201-2b ',\n",
       " '80001',\n",
       " 'GSK EMU-SOW16',\n",
       " 'CTMX-904-101',\n",
       " 'MR_MATRIX',\n",
       " 'mCRPC_BIOBANK',\n",
       " 'A5481092',\n",
       " 'TAK-103 LBx Pilot 2023',\n",
       " 'MS201924_0001',\n",
       " '201-P1 C3 ',\n",
       " 'ART4215C001',\n",
       " 'C4221015',\n",
       " 'M18-868',\n",
       " 'TT816-12-001',\n",
       " '201-P1 C3',\n",
       " 'JCOG1801 A1',\n",
       " 'M21-404',\n",
       " 'GSK-EMU-021',\n",
       " 'ACT16444',\n",
       " 'XmAb23104-01',\n",
       " 'ID-VDP-103',\n",
       " 'IB-SASOW12_1',\n",
       " 'RP-3500-01',\n",
       " 'CA116-001',\n",
       " 'I3Y-MC-JPEF',\n",
       " 'OSU_BR',\n",
       " '459073',\n",
       " 'CGG21-016P',\n",
       " 'GS-US-467-5643',\n",
       " 'ATA188',\n",
       " 'ONO-4578-04',\n",
       " 'METRICS',\n",
       " 'ONO-4578-03',\n",
       " 'eFT226-0002',\n",
       " 'OSU_01',\n",
       " 'GSK-EMU-SOW23-2',\n",
       " 'PBI-200-101',\n",
       " 'NOPRODLUC002',\n",
       " 'CL003_1',\n",
       " 'RMC-9805-001',\n",
       " '18-301',\n",
       " 'GSK-TRACER-3',\n",
       " 'NADIM II',\n",
       " 'ART0380C002',\n",
       " 'IDE397-001',\n",
       " 'D926NC00001',\n",
       " 'MS201924_0020',\n",
       " 'TAK-102-1501',\n",
       " '18595',\n",
       " 'TTX-080-001',\n",
       " '20210023',\n",
       " 'ATA129-201',\n",
       " 'BTBC',\n",
       " 'RMC-6236-001',\n",
       " 'GHStudy',\n",
       " '201-P2',\n",
       " 'SOW 148',\n",
       " '20190172',\n",
       " 'ART0380C001',\n",
       " 'GSK-EMU-024',\n",
       " 'VT3989-001',\n",
       " 'THOR-707-101',\n",
       " 'GSK-EMU-SOW23-1',\n",
       " '18594',\n",
       " 'EPI-7386-CS-001',\n",
       " 'GSK- EMU- 17A',\n",
       " '2029-001',\n",
       " 'ST-067-001',\n",
       " 'C4221022',\n",
       " 'B7461006',\n",
       " 'EP0031',\n",
       " 'IMMU-132-09',\n",
       " 'CHIP_MATRIX',\n",
       " 'D933AC00001',\n",
       " 'D3610C00001',\n",
       " '201-P1 2c',\n",
       " 'VT3996-301',\n",
       " '201-1 ',\n",
       " 'MCLA-158-CL01',\n",
       " 'ONO-4578-05',\n",
       " 'PROTEUS']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "study_id_of_interest"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "1cbe91f3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of ids not detected : 40\n"
     ]
    }
   ],
   "source": [
    "print (\"Number of ids not detected :\",len(ids_not_detected))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "75f6c5bf",
   "metadata": {},
   "source": [
    "# Final dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "2908c756",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_all = df_all[['Study_ID','Cancertype']].drop_duplicates(keep = 'first')\n",
    "df_all['Cancertype'] = df_all['Cancertype'].fillna('-')\n",
    "df_all = df_all[~df_all['Study_ID'].isna()]\n",
    "df_all.index = np.arange(0,len(df_all))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "25927a5f",
   "metadata": {},
   "outputs": [],
   "source": [
    "for var in range (0,len(df_all)):\n",
    "    buf = str(df_all.iloc[var]['Study_ID'])\n",
    "    clinical_trial.loc[clinical_trial['Other IDs'].fillna('-').apply(lambda x:buf in x),'Study_ID'] = buf\n",
    "    clinical_trial.loc[clinical_trial['Other IDs'].fillna('-').apply(lambda x:buf in x),'Cancertype'] = ', '.join(list(df_all[df_all.Study_ID == buf]['Cancertype']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "ef2c97cd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/ghsfa/projects/pharma/scratch/gyalamanchili/clinical_trial_data_leverage\n"
     ]
    }
   ],
   "source": [
    "!pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "cab5677d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study_id_Guardant_Infinity</th>\n",
       "      <th>Cancertype_Guardant_Infinity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>937</th>\n",
       "      <td>NCT04901806</td>\n",
       "      <td>Study of PBI-200 in Subjects With NTRK-Fusion-...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04901806</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is a first-in-human, Phase 1/2 open-label...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor, Adult|Brain Tumor, Primary|Desmop...</td>\n",
       "      <td>DRUG: PBI-200</td>\n",
       "      <td>Pyramid Biosciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>PBI-200-101</td>\n",
       "      <td>PBI-200-101</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2871</th>\n",
       "      <td>NCT03052608</td>\n",
       "      <td>A Study Of Lorlatinib Versus Crizotinib In Fir...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03052608</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>A phase 3 study to demonstrate whether lorlati...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>DRUG: Lorlatinib|DRUG: Crizotinib</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>B7461006|2016-003315-35</td>\n",
       "      <td>B7461006</td>\n",
       "      <td>Lung Cancer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4940</th>\n",
       "      <td>NCT04913220</td>\n",
       "      <td>A Study of SAR444245 Combined With Cemiplimab ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04913220</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Primary Objective:\\n\\n-To determine the antitu...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malignant Melanoma|Squamous Cell Carcinoma of ...</td>\n",
       "      <td>DRUG: THOR-707|DRUG: Cemiplimab</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ACT16845|U1111-1254-0189|2020-005332-30</td>\n",
       "      <td>ACT16845</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6913</th>\n",
       "      <td>NCT04657068</td>\n",
       "      <td>A Study of ART0380 for the Treatment of Advanc...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04657068</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This clinical trial is evaluating a drug calle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Cancer|Metastatic Cancer|Ovarian Canc...</td>\n",
       "      <td>DRUG: ART0380|DRUG: Gemcitabine|DRUG: Irinotecan</td>\n",
       "      <td>Artios Pharma Ltd</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ART0380C001</td>\n",
       "      <td>ART0380C001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10479</th>\n",
       "      <td>NCT04976803</td>\n",
       "      <td>Tissue Collection for Correlation Between ATM ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04976803</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This study examines the correlation between AT...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor, Unspecified, Adult</td>\n",
       "      <td>OTHER: Determination of ATM alteration status.</td>\n",
       "      <td>Artios Pharma Ltd</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>ART0380C002</td>\n",
       "      <td>ART0380C002</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13464</th>\n",
       "      <td>NCT04267939</td>\n",
       "      <td>ATR Inhibitor Elimusertib (BAY1895344) Plus Ni...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04267939</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The purpose of the study is to test how well p...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Tumors (Excluding Prostate Canc...</td>\n",
       "      <td>DRUG: Elimusertib (BAY1895344)|DRUG: Niraparib</td>\n",
       "      <td>Bayer</td>\n",
       "      <td>GlaxoSmithKline</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>18595|2018-003930-34</td>\n",
       "      <td>18595</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14419</th>\n",
       "      <td>NCT03901339</td>\n",
       "      <td>Study of Sacituzumab Govitecan-hziy Versus Tre...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03901339</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of this study is to asse...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>DRUG: Sacituzumab Govitecan-hziy|DRUG: Eribuli...</td>\n",
       "      <td>Gilead Sciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>IMMU-132-09|2018-004201-33</td>\n",
       "      <td>IMMU-132-09</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15178</th>\n",
       "      <td>NCT04316039</td>\n",
       "      <td>Radiotherapy Versus Radiotherapy Combined With...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04316039</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>It has been reported that radiation therapy fo...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Low-grade Glioma</td>\n",
       "      <td>DRUG: Temozolomide|RADIATION: intensity modula...</td>\n",
       "      <td>West China Hospital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ChiCTR1800015199</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16549</th>\n",
       "      <td>NCT04229979</td>\n",
       "      <td>Galinpepimut-S Versus Investigator's Choice of...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04229979</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>To assess the safety and efficacy of galinpepi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Acute Myeloid Leukemia</td>\n",
       "      <td>BIOLOGICAL: Galinpepimut-S|DRUG: Azacitidine|D...</td>\n",
       "      <td>Sellas Life Sciences Group</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>SLSG18-301</td>\n",
       "      <td>18-301</td>\n",
       "      <td>Endometrial Carcinoma, -</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17927</th>\n",
       "      <td>NCT04421222</td>\n",
       "      <td>Oral EPI-7386 in Patients With Castration-Resi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04421222</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a phase I, clinical research study of ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>DRUG: EPI-7386 (QD)|DRUG: EPI-7386 (BID)|DRUG:...</td>\n",
       "      <td>ESSA Pharmaceuticals</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>EPI-7386-CS-001</td>\n",
       "      <td>EPI-7386-CS-001</td>\n",
       "      <td>Prostate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20300</th>\n",
       "      <td>NCT01660087</td>\n",
       "      <td>Diagnosis of Lung Cancer From Exhaled Breath W...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01660087</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The overall objective of this proposal is to d...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Lung Cancer</td>\n",
       "      <td>DEVICE: Biophotonic platform for VOC detection</td>\n",
       "      <td>National University Hospital, Singapore</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>SERC/1121480001</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24891</th>\n",
       "      <td>NCT05379985</td>\n",
       "      <td>Study of RMC-6236 in Patients With Advanced So...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05379985</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Evaluate the safety and tolerability of RMC-62...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-small Cell Lung Cancer (NSCLC)|Colorectal ...</td>\n",
       "      <td>DRUG: RMC-6236</td>\n",
       "      <td>Revolution Medicines, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>RMC-6236-001</td>\n",
       "      <td>RMC-6236-001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30304</th>\n",
       "      <td>NCT05169567</td>\n",
       "      <td>Abemaciclib (LY2835219) Plus Fulvestrant Compa...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05169567</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This study will evaluate the effect of adding ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Neoplasm|Neoplasm Metastasis</td>\n",
       "      <td>DRUG: Abemaciclib|DRUG: Fulvestrant|DRUG: Placebo</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>18238|I3Y-MC-JPEF|2021-002301-10</td>\n",
       "      <td>I3Y-MC-JPEF</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33651</th>\n",
       "      <td>NCT04070443</td>\n",
       "      <td>Safety and Efficacy of Ponatinib Followed by I...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04070443</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The investigators hypothesize that, in newly d...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Philadelphia Chromosome Positive CML|BCR-ABL P...</td>\n",
       "      <td>DRUG: Ponatinib|DRUG: Imatinib</td>\n",
       "      <td>Centre Leon Berard</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ET18000120 (TIPI)</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35339</th>\n",
       "      <td>NCT05396833</td>\n",
       "      <td>Study of M1774 in Combination With DNA Damage ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05396833</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is an open-label, multicenter, clinical s...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Metastatic or Locally Advanced Unresectable So...</td>\n",
       "      <td>DRUG: M1774|DRUG: M4076|DRUG: Avelumab</td>\n",
       "      <td>EMD Serono Research &amp; Development Institute, Inc.</td>\n",
       "      <td>Merck KGaA, Darmstadt, Germany</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>MS201924_0020|2022-500287-35-00</td>\n",
       "      <td>MS201924_0020</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36226</th>\n",
       "      <td>NCT03497533</td>\n",
       "      <td>Treatment of Refractory/Relapsed Non-Hodgkin L...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03497533</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>This is a single arm, open-label, single-cente...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-hodgkin Lymphoma,B Cell</td>\n",
       "      <td>BIOLOGICAL: TriCAR-T-CD19</td>\n",
       "      <td>Timmune Biotech Inc.</td>\n",
       "      <td>Hunan Provincial People's Hospital</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ChiCTR1800014528</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37082</th>\n",
       "      <td>NCT04665206</td>\n",
       "      <td>Study to Evaluate VT3989 in Patients With Meta...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04665206</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is an open-label, dose escalation and exp...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor, Adult|Mesothelioma</td>\n",
       "      <td>DRUG: VT3989</td>\n",
       "      <td>Vivace Therapeutics, Inc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>VT3989-001</td>\n",
       "      <td>VT3989-001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38509</th>\n",
       "      <td>NCT03675893</td>\n",
       "      <td>Abemaciclib + Letrozole +/- Metformin in Recur...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03675893</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This research study is studying a combination ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Endometrial Cancer</td>\n",
       "      <td>DRUG: Letrozole|DRUG: Abemaciclib|DRUG: LY3023...</td>\n",
       "      <td>Dana-Farber Cancer Institute</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>18-301</td>\n",
       "      <td>18-301</td>\n",
       "      <td>Endometrial Carcinoma, -</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40097</th>\n",
       "      <td>NCT03574168</td>\n",
       "      <td>CD19-CAR-T Cells in Patients With R/R B-ALL</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03574168</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>This is a single center, single arm, open-labl...</td>\n",
       "      <td>NO</td>\n",
       "      <td>B-cell Acute Lymphoblastic Leukemia</td>\n",
       "      <td>BIOLOGICAL: CD19-CAR-T Cells</td>\n",
       "      <td>Bioceltech Therapeutics, Ltd.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>BT-ALL-001-v2|ChiCTR1800016541</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40848</th>\n",
       "      <td>NCT04497116</td>\n",
       "      <td>Study of RP-3500, Camonsertib, in Advanced Sol...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04497116</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The primary purpose of this study is to define...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Tumor</td>\n",
       "      <td>DRUG: RP-3500 (camonsertib)|DRUG: Talazoparib|...</td>\n",
       "      <td>Repare Therapeutics</td>\n",
       "      <td>Roche Pharma AG</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>RP-3500-01|2020-000301-87</td>\n",
       "      <td>RP-3500-01</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40889</th>\n",
       "      <td>NCT01226316</td>\n",
       "      <td>Safety, Tolerability &amp; Potential Anti-cancer A...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01226316</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This study is designed to investigate the safe...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Malignancy|Safety and Tolerabil...</td>\n",
       "      <td>DRUG: AZD5363|DRUG: AZD5363|DRUG: AZD5363|DRUG...</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>D3610C00001|EudraCT number: 2010-022167-35</td>\n",
       "      <td>D3610C00001</td>\n",
       "      <td>Breast , mCRPC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41384</th>\n",
       "      <td>NCT05199168</td>\n",
       "      <td>Visualization Versus Intraoperative Neuromonit...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05199168</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The clinical value of intraoperative nerve mon...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Esophageal Cancer</td>\n",
       "      <td>PROCEDURE: intraoperative nerve monitoring</td>\n",
       "      <td>Tianjin Medical University Cancer Institute an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>E20210023</td>\n",
       "      <td>20210023</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45008</th>\n",
       "      <td>NCT05387265</td>\n",
       "      <td>A Trial to Find Safe and Active Doses for an I...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05387265</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this first-in-human study, CTMX...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumors</td>\n",
       "      <td>DRUG: CX-904</td>\n",
       "      <td>CytomX Therapeutics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>CTMX-904-101</td>\n",
       "      <td>CTMX-904-101</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45624</th>\n",
       "      <td>NCT03188965</td>\n",
       "      <td>First-in-human Study of ATR Inhibitor BAY18953...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03188965</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The ATR (ataxia-telangiectasia and Rad3 relate...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Tumor|Non-Hodgkin's Lymphoma|Ma...</td>\n",
       "      <td>DRUG: Elimusertib (BAY1895344)</td>\n",
       "      <td>Bayer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>18594|2016-004484-39</td>\n",
       "      <td>18594</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45894</th>\n",
       "      <td>NCT04787042</td>\n",
       "      <td>Phase 1a and Phase 2 Study for Safety, Prelimi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04787042</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a multiphase, multicenter study, which...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cancer|Solid Tumor|Melanoma|Renal Cell Carcino...</td>\n",
       "      <td>BIOLOGICAL: ST-067|BIOLOGICAL: Obinutuzumab 25...</td>\n",
       "      <td>Simcha IL-18, Inc.</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ST-067-001|KEYNOTE-E64</td>\n",
       "      <td>ST-067-001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46236</th>\n",
       "      <td>NCT05071053</td>\n",
       "      <td>Tusamitamab Ravtansine (SAR408701) in Combinat...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05071053</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Primary Objectives:\\n\\nPart 1: to confirm the ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Adenocarcinoma Gastric|Gastrooesophageal Cancer</td>\n",
       "      <td>DRUG: Ramucirumab (CYRAMZAÂ®)|DRUG: Tusamitamab...</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ACT16444|U1111-1266-5040|2021-001967-26</td>\n",
       "      <td>ACT16444</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46358</th>\n",
       "      <td>NCT04170153</td>\n",
       "      <td>M1774 in Participants With Metastatic or Local...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04170153</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is an open-label, Phase I, first-in-human...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Metastatic or Locally Advanced Unresectable So...</td>\n",
       "      <td>DRUG: M1774|DRUG: Niraparib</td>\n",
       "      <td>EMD Serono Research &amp; Development Institute, Inc.</td>\n",
       "      <td>Merck KGaA, Darmstadt, Germany</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>MS201924_0001|2019-002203-18</td>\n",
       "      <td>MS201924_0001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48919</th>\n",
       "      <td>NCT04607421</td>\n",
       "      <td>A Study of Encorafenib Plus Cetuximab With or ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04607421</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this study is to evaluate two s...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Neoplasms</td>\n",
       "      <td>DRUG: Encorafenib|DRUG: Cetuximab|DRUG: Oxalip...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Ono Pharmaceutical Co. Ltd|Merck KGaA, Darmsta...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>C4221015|2020-001288-99|BREAKWATER</td>\n",
       "      <td>C4221015</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49719</th>\n",
       "      <td>NCT03155061</td>\n",
       "      <td>Study of ONO-4578 With and Without ONO-4538 in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03155061</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The objective of the study is to evaluate the ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced or Metastatic Solid Tumors</td>\n",
       "      <td>DRUG: ONO-4578|DRUG: ONO-4538</td>\n",
       "      <td>Ono Pharmaceutical Co. Ltd</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ONO-4578-01</td>\n",
       "      <td>ONO-4578-01</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52182</th>\n",
       "      <td>NCT03787953</td>\n",
       "      <td>A Real World Study of Anti-PD-1/PD-L1 Antibodi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03787953</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The study was designed to analyze the efficacy...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Tumors</td>\n",
       "      <td>DRUG: Anti-PD-1/PD-L1 antibodies</td>\n",
       "      <td>Chinese PLA General Hospital</td>\n",
       "      <td>LinkDoc Technology (Beijing) Co. Ltd.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>PDL1-2018-301BJ</td>\n",
       "      <td>18-301</td>\n",
       "      <td>Endometrial Carcinoma, -</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52296</th>\n",
       "      <td>NCT04972110</td>\n",
       "      <td>Study of RP-3500 (Camonsertib) With Niraparib ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04972110</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The primary purpose of this study is to assess...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Tumor, Adult</td>\n",
       "      <td>DRUG: RP-3500 (camonsertib)</td>\n",
       "      <td>Repare Therapeutics</td>\n",
       "      <td>Roche Pharma AG</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>RP-3500-03</td>\n",
       "      <td>RP-3500-03</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52616</th>\n",
       "      <td>NCT04928846</td>\n",
       "      <td>A Study to Assess Disease Activity and Adverse...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04928846</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Cancer is a condition where cells in a specifi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non Small Cell Lung Cancer</td>\n",
       "      <td>BIOLOGICAL: Telisotuzumab Vedotin|DRUG: Docetaxel</td>\n",
       "      <td>AbbVie</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>M18-868|2021-001811-94</td>\n",
       "      <td>M18-868</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54647</th>\n",
       "      <td>NCT01028495</td>\n",
       "      <td>A Safety and Efficacy Study of RX-0201 Plus Ge...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01028495</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To assess the safety and efficacy of a combine...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Metastatic Pancreatic Cancer</td>\n",
       "      <td>DRUG: RX-0201 plus Gemcitabine</td>\n",
       "      <td>Rexahn Pharmaceuticals, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>RX-0201-P2-A-07</td>\n",
       "      <td>201-P2</td>\n",
       "      <td>Extranodal NK/T-cell lymphoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56462</th>\n",
       "      <td>NCT03412994</td>\n",
       "      <td>Clinical Study of Apatinib Combined With Secon...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03412994</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>(1) Evaluate the efficacy of apatinib in combi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Colorectal Neoplasms</td>\n",
       "      <td>DRUG: Apatinib|DRUG: standard second-line chem...</td>\n",
       "      <td>Liqiang Zhong</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ChiCTR1800014478</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59633</th>\n",
       "      <td>NCT05166577</td>\n",
       "      <td>Nanatinostat Plus Valganciclovir in Patients W...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05166577</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This study will evaluate the safety and effica...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Nasopharyngeal Carcinoma|EBV-Related Gastric C...</td>\n",
       "      <td>DRUG: Nanatinostat|DRUG: Nanatinostat|DRUG: Va...</td>\n",
       "      <td>Viracta Therapeutics, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>VT3996-301</td>\n",
       "      <td>VT3996-301</td>\n",
       "      <td>NPC-Undifferentiated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60402</th>\n",
       "      <td>NCT04405778</td>\n",
       "      <td>A Study of TAK-102 in Adult With Previously-Tr...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04405778</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Some solid tumors make a lot of a protein call...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumors</td>\n",
       "      <td>BIOLOGICAL: TAK-102</td>\n",
       "      <td>Takeda</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TAK-102-1501|U1111-1247-6429|jRCT1080225204</td>\n",
       "      <td>TAK-102-1501</td>\n",
       "      <td>Liposarcoma, HepatoCellular Carcinoma, Gastric...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60620</th>\n",
       "      <td>NCT03313778</td>\n",
       "      <td>Safety, Tolerability, and Immunogenicity of mR...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03313778</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The purpose of this study is to assess the saf...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumors</td>\n",
       "      <td>BIOLOGICAL: mRNA-4157|BIOLOGICAL: Pembrolizumab</td>\n",
       "      <td>ModernaTX, Inc.</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>mRNA-4157-P101</td>\n",
       "      <td>mRNA-4157-P101</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61011</th>\n",
       "      <td>NCT05006794</td>\n",
       "      <td>Study to Evaluate the Safety, Tolerability, an...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05006794</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a Phase I open-label, multi-center stu...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Malignancies</td>\n",
       "      <td>DRUG: GS-9716|DRUG: Docetaxel|DRUG: sacituzuma...</td>\n",
       "      <td>Gilead Sciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>GS-US-467-5643</td>\n",
       "      <td>GS-US-467-5643</td>\n",
       "      <td>-, Colon, Rectal, NSCLC, Colorectal, Uterine â€“...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65382</th>\n",
       "      <td>NCT05687266</td>\n",
       "      <td>Study of Datopotamab Deruxtecan (Dato-DXd) in ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05687266</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a Phase III, randomized, open-label, m...</td>\n",
       "      <td>NO</td>\n",
       "      <td>NSCLC</td>\n",
       "      <td>DRUG: Datopotamab deruxtecan|DRUG: Durvalumab|...</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>D926NC00001|2021-004606-21</td>\n",
       "      <td>D926NC00001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66569</th>\n",
       "      <td>NCT03585725</td>\n",
       "      <td>A Pilot Investigator-Initiated Study of Ribavi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03585725</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>This is a A Pilot Investigator-Initiated Study...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Follicular Lymphoma|Mantle Cell Lymphoma</td>\n",
       "      <td>DRUG: Ribavirin</td>\n",
       "      <td>Weill Medical College of Cornell University</td>\n",
       "      <td>Memorial Sloan Kettering Cancer Center</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>1709018594</td>\n",
       "      <td>18594</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68631</th>\n",
       "      <td>NCT03519230</td>\n",
       "      <td>Maintenance Treatment With BGB-290 Versus Plac...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03519230</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>To evaluate the efficacy, safety and tolerabil...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>DRUG: Pamiparib capsule|DRUG: Placebo capsule</td>\n",
       "      <td>BeiGene</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>BGB-290-302|ChiCTR1800014643|CTR20171666</td>\n",
       "      <td>80001</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70405</th>\n",
       "      <td>NCT05198934</td>\n",
       "      <td>Sotorasib and Panitumumab Versus Investigator'...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05198934</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of the study is to compare progression...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Colorectal Cancer (CRC)</td>\n",
       "      <td>DRUG: Sotorasib|DRUG: Panitumumab|DRUG: Triflu...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20190172</td>\n",
       "      <td>20190172</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71607</th>\n",
       "      <td>NCT03631784</td>\n",
       "      <td>A Trial of Pembrolizumab in Combination With C...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03631784</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is a trial in adult participants with unr...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Non-small Cell Lung Cancer</td>\n",
       "      <td>DRUG: Pembrolizumab 200 mg|DRUG: Paclitaxel 45...</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>3475-799|MK-3475-799|2018-000714-37</td>\n",
       "      <td>MK-3475-799</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72052</th>\n",
       "      <td>NCT02089334</td>\n",
       "      <td>Dose-Finding, Safety and Efficacy Study of RX-...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02089334</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The purpose of this study is to determine the ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Metastatic Renal Cell Cancer</td>\n",
       "      <td>DRUG: RX-0201</td>\n",
       "      <td>Rexahn Pharmaceuticals, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>RX-0201-P2-A-09</td>\n",
       "      <td>201-P2</td>\n",
       "      <td>Extranodal NK/T-cell lymphoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72434</th>\n",
       "      <td>NCT05094336</td>\n",
       "      <td>AMG 193, Methylthioadenosine (MTA) Cooperative...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05094336</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The primary objective of Parts 1 and 2 of this...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced MTAP-null Solid Tumors</td>\n",
       "      <td>DRUG: AMG 193|DRUG: Docetaxel|DRUG: Comparator...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>20210023</td>\n",
       "      <td>20210023</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73090</th>\n",
       "      <td>NCT04092673</td>\n",
       "      <td>Study of eFT226 in Subjects With Selected Adva...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04092673</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This clinical trial is a Phase 1-2, open-label...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor, Adult</td>\n",
       "      <td>DRUG: eFT226|DRUG: Sotorasib|DRUG: Fulvestrant...</td>\n",
       "      <td>Effector Therapeutics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>eFT226-0002</td>\n",
       "      <td>eFT226-0002</td>\n",
       "      <td>Breast, BREAST</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75749</th>\n",
       "      <td>NCT05029882</td>\n",
       "      <td>Study to Assess Adverse Events and Change in D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05029882</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Cancer is a condition where cells in a specifi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-Small Cell Lung Cancer|Advanced Solid Tumo...</td>\n",
       "      <td>DRUG: ABBV-400</td>\n",
       "      <td>AbbVie</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>M21-404|2021-002258-98</td>\n",
       "      <td>M21-404</td>\n",
       "      <td>-, Acral melanoma, CRC, Bladder Cancer, TNBC, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76276</th>\n",
       "      <td>NCT03838159</td>\n",
       "      <td>NADIM II: Neo-Adjuvant Immunotherapy</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03838159</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is an open-label, randomised, two-arm, ph...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non Small Cell Lung Cancer</td>\n",
       "      <td>DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Nivol...</td>\n",
       "      <td>FundaciÃ³n GECP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>GECP 18/02_NADIM II|2018-004515-45</td>\n",
       "      <td>NADIM II</td>\n",
       "      <td>Adenocarcinoma, Squamous, NOS/Undifferentiated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82781</th>\n",
       "      <td>NCT03709680</td>\n",
       "      <td>Study Of Palbociclib Combined With Chemotherap...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03709680</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>A study to learn about safety and find out max...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ewing Sarcoma|Solid Tumors|Rhabdoid Tumor|Rhab...</td>\n",
       "      <td>DRUG: Palbociclib|DRUG: Temozolomide|DRUG: Iri...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Children's Oncology Group (COG)</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>A5481092|2021-003444-25</td>\n",
       "      <td>A5481092</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83712</th>\n",
       "      <td>NCT03752398</td>\n",
       "      <td>A Study of XmAbÂ®23104 in Subjects With Selecte...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03752398</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a Phase 1, multiple dose, ascending do...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Melanoma (Excluding Uveal Melanoma)|Cervical C...</td>\n",
       "      <td>BIOLOGICAL: XmAbÂ®23104|BIOLOGICAL: YervoyÂ® (ip...</td>\n",
       "      <td>Xencor, Inc.</td>\n",
       "      <td>ICON plc</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>XmAb23104-01|DUET-3</td>\n",
       "      <td>XmAb23104-01</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88829</th>\n",
       "      <td>NCT04794699</td>\n",
       "      <td>Study of IDE397 in Participants With Solid Tum...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04794699</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a Phase 1, open-label, multicenter, do...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor</td>\n",
       "      <td>DRUG: IDE397|DRUG: Docetaxel|DRUG: Paclitaxel</td>\n",
       "      <td>IDEAYA Biosciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>IDE397-001</td>\n",
       "      <td>IDE397-001</td>\n",
       "      <td>-, Head and Neck, Melanoma, Pancreas, Cholangi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89979</th>\n",
       "      <td>NCT03139370</td>\n",
       "      <td>Safety and Efficacy of MAGE-A3/A6 T Cell Recep...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03139370</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The primary objectives of Phase 1A are to eval...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor</td>\n",
       "      <td>DRUG: KITE-718|DRUG: Cyclophosphamide|DRUG: Fl...</td>\n",
       "      <td>Kite, A Gilead Company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>KITE-718-301|2020-005456-37</td>\n",
       "      <td>18-301</td>\n",
       "      <td>Endometrial Carcinoma, -</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90702</th>\n",
       "      <td>NCT04009681</td>\n",
       "      <td>A Study Evaluating Safety and Therapeutic Acti...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04009681</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Primary Objectives:\\n\\n* Evaluate the safety a...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Metastasis</td>\n",
       "      <td>DRUG: THOR-707|DRUG: Checkpoint inhibitor|DRUG...</td>\n",
       "      <td>Synthorx, Inc, a Sanofi company</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>THOR-707-101 (TCD16843)</td>\n",
       "      <td>THOR-707-101</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95478</th>\n",
       "      <td>NCT04991480</td>\n",
       "      <td>A Study of ART4215 for the Treatment of Advanc...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04991480</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This clinical trial is evaluating a drug calle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Cancer|Metastatic Cancer|Breast Cancer</td>\n",
       "      <td>DRUG: ART4215|DRUG: Talazoparib|DRUG: Niraparib</td>\n",
       "      <td>Artios Pharma Ltd</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ART4215C001</td>\n",
       "      <td>ART4215C001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99057</th>\n",
       "      <td>NCT03875235</td>\n",
       "      <td>Durvalumab or Placebo in Combination With Gemc...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03875235</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Durvalumab or Placebo in Combination With Gemc...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Biliary Tract Neoplasms</td>\n",
       "      <td>DRUG: Durvalumab|DRUG: Placebo</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>D933AC00001|2018-004688-30</td>\n",
       "      <td>D933AC00001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100156</th>\n",
       "      <td>NCT03526835</td>\n",
       "      <td>A Study of Bispecific Antibody MCLA-158 in Pat...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03526835</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a Phase 1/2 open-label, multi-center, ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced/Metastatic Solid Tumors|Colorectal Ca...</td>\n",
       "      <td>DRUG: MCLA-158</td>\n",
       "      <td>Merus N.V.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>MCLA-158-CL01|2017-004745-24</td>\n",
       "      <td>MCLA-158-CL01</td>\n",
       "      <td>Gastric, HNSCC, GEA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100250</th>\n",
       "      <td>NCT04933669</td>\n",
       "      <td>Prospective Multicenter Clinical Study of Neoa...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04933669</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The R0 resection rate of gastrointestinal stro...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Progression-free Survival|Gastrointestinal Str...</td>\n",
       "      <td>DRUG: Imatinib</td>\n",
       "      <td>First Affiliated Hospital of Zhejiang University</td>\n",
       "      <td>Second Affiliated Hospital, School of Medicine...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>IIT20210023C-R1</td>\n",
       "      <td>20210023</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100563</th>\n",
       "      <td>NCT03543813</td>\n",
       "      <td>PROCLAIM-CX-2029: A Trial to Find Safe and Act...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03543813</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The purpose of this first-in-human study of CX...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Solid Tumor, Adult|Head and Neck Cancer|Non Sm...</td>\n",
       "      <td>DRUG: CX-2029</td>\n",
       "      <td>CytomX Therapeutics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>CTMX-M-2029-001</td>\n",
       "      <td>2029-001</td>\n",
       "      <td>-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101289</th>\n",
       "      <td>NCT04485013</td>\n",
       "      <td>TTX-080 HLA-G Antagonist in Subjects With Adva...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04485013</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>TTX-080-001 is a Phase 1, open label, dose esc...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>DRUG: TTX-080|DRUG: TTX-080|DRUG: pembrolizuma...</td>\n",
       "      <td>Tizona Therapeutics, Inc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>TTX-080-001</td>\n",
       "      <td>TTX-080-001</td>\n",
       "      <td>CRC, HNSCC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         NCT Number                                        Study Title  \\\n",
       "937     NCT04901806  Study of PBI-200 in Subjects With NTRK-Fusion-...   \n",
       "2871    NCT03052608  A Study Of Lorlatinib Versus Crizotinib In Fir...   \n",
       "4940    NCT04913220  A Study of SAR444245 Combined With Cemiplimab ...   \n",
       "6913    NCT04657068  A Study of ART0380 for the Treatment of Advanc...   \n",
       "10479   NCT04976803  Tissue Collection for Correlation Between ATM ...   \n",
       "13464   NCT04267939  ATR Inhibitor Elimusertib (BAY1895344) Plus Ni...   \n",
       "14419   NCT03901339  Study of Sacituzumab Govitecan-hziy Versus Tre...   \n",
       "15178   NCT04316039  Radiotherapy Versus Radiotherapy Combined With...   \n",
       "16549   NCT04229979  Galinpepimut-S Versus Investigator's Choice of...   \n",
       "17927   NCT04421222  Oral EPI-7386 in Patients With Castration-Resi...   \n",
       "20300   NCT01660087  Diagnosis of Lung Cancer From Exhaled Breath W...   \n",
       "24891   NCT05379985  Study of RMC-6236 in Patients With Advanced So...   \n",
       "30304   NCT05169567  Abemaciclib (LY2835219) Plus Fulvestrant Compa...   \n",
       "33651   NCT04070443  Safety and Efficacy of Ponatinib Followed by I...   \n",
       "35339   NCT05396833  Study of M1774 in Combination With DNA Damage ...   \n",
       "36226   NCT03497533  Treatment of Refractory/Relapsed Non-Hodgkin L...   \n",
       "37082   NCT04665206  Study to Evaluate VT3989 in Patients With Meta...   \n",
       "38509   NCT03675893  Abemaciclib + Letrozole +/- Metformin in Recur...   \n",
       "40097   NCT03574168        CD19-CAR-T Cells in Patients With R/R B-ALL   \n",
       "40848   NCT04497116  Study of RP-3500, Camonsertib, in Advanced Sol...   \n",
       "40889   NCT01226316  Safety, Tolerability & Potential Anti-cancer A...   \n",
       "41384   NCT05199168  Visualization Versus Intraoperative Neuromonit...   \n",
       "45008   NCT05387265  A Trial to Find Safe and Active Doses for an I...   \n",
       "45624   NCT03188965  First-in-human Study of ATR Inhibitor BAY18953...   \n",
       "45894   NCT04787042  Phase 1a and Phase 2 Study for Safety, Prelimi...   \n",
       "46236   NCT05071053  Tusamitamab Ravtansine (SAR408701) in Combinat...   \n",
       "46358   NCT04170153  M1774 in Participants With Metastatic or Local...   \n",
       "48919   NCT04607421  A Study of Encorafenib Plus Cetuximab With or ...   \n",
       "49719   NCT03155061  Study of ONO-4578 With and Without ONO-4538 in...   \n",
       "52182   NCT03787953  A Real World Study of Anti-PD-1/PD-L1 Antibodi...   \n",
       "52296   NCT04972110  Study of RP-3500 (Camonsertib) With Niraparib ...   \n",
       "52616   NCT04928846  A Study to Assess Disease Activity and Adverse...   \n",
       "54647   NCT01028495  A Safety and Efficacy Study of RX-0201 Plus Ge...   \n",
       "56462   NCT03412994  Clinical Study of Apatinib Combined With Secon...   \n",
       "59633   NCT05166577  Nanatinostat Plus Valganciclovir in Patients W...   \n",
       "60402   NCT04405778  A Study of TAK-102 in Adult With Previously-Tr...   \n",
       "60620   NCT03313778  Safety, Tolerability, and Immunogenicity of mR...   \n",
       "61011   NCT05006794  Study to Evaluate the Safety, Tolerability, an...   \n",
       "65382   NCT05687266  Study of Datopotamab Deruxtecan (Dato-DXd) in ...   \n",
       "66569   NCT03585725  A Pilot Investigator-Initiated Study of Ribavi...   \n",
       "68631   NCT03519230  Maintenance Treatment With BGB-290 Versus Plac...   \n",
       "70405   NCT05198934  Sotorasib and Panitumumab Versus Investigator'...   \n",
       "71607   NCT03631784  A Trial of Pembrolizumab in Combination With C...   \n",
       "72052   NCT02089334  Dose-Finding, Safety and Efficacy Study of RX-...   \n",
       "72434   NCT05094336  AMG 193, Methylthioadenosine (MTA) Cooperative...   \n",
       "73090   NCT04092673  Study of eFT226 in Subjects With Selected Adva...   \n",
       "75749   NCT05029882  Study to Assess Adverse Events and Change in D...   \n",
       "76276   NCT03838159               NADIM II: Neo-Adjuvant Immunotherapy   \n",
       "82781   NCT03709680  Study Of Palbociclib Combined With Chemotherap...   \n",
       "83712   NCT03752398  A Study of XmAbÂ®23104 in Subjects With Selecte...   \n",
       "88829   NCT04794699  Study of IDE397 in Participants With Solid Tum...   \n",
       "89979   NCT03139370  Safety and Efficacy of MAGE-A3/A6 T Cell Recep...   \n",
       "90702   NCT04009681  A Study Evaluating Safety and Therapeutic Acti...   \n",
       "95478   NCT04991480  A Study of ART4215 for the Treatment of Advanc...   \n",
       "99057   NCT03875235  Durvalumab or Placebo in Combination With Gemc...   \n",
       "100156  NCT03526835  A Study of Bispecific Antibody MCLA-158 in Pat...   \n",
       "100250  NCT04933669  Prospective Multicenter Clinical Study of Neoa...   \n",
       "100563  NCT03543813  PROCLAIM-CX-2029: A Trial to Find Safe and Act...   \n",
       "101289  NCT04485013  TTX-080 HLA-G Antagonist in Subjects With Adva...   \n",
       "\n",
       "                                           Study URL           Study Status  \\\n",
       "937     https://clinicaltrials.gov/study/NCT04901806  ACTIVE_NOT_RECRUITING   \n",
       "2871    https://clinicaltrials.gov/study/NCT03052608  ACTIVE_NOT_RECRUITING   \n",
       "4940    https://clinicaltrials.gov/study/NCT04913220  ACTIVE_NOT_RECRUITING   \n",
       "6913    https://clinicaltrials.gov/study/NCT04657068             RECRUITING   \n",
       "10479   https://clinicaltrials.gov/study/NCT04976803              COMPLETED   \n",
       "13464   https://clinicaltrials.gov/study/NCT04267939  ACTIVE_NOT_RECRUITING   \n",
       "14419   https://clinicaltrials.gov/study/NCT03901339              COMPLETED   \n",
       "15178   https://clinicaltrials.gov/study/NCT04316039             RECRUITING   \n",
       "16549   https://clinicaltrials.gov/study/NCT04229979             RECRUITING   \n",
       "17927   https://clinicaltrials.gov/study/NCT04421222             RECRUITING   \n",
       "20300   https://clinicaltrials.gov/study/NCT01660087              WITHDRAWN   \n",
       "24891   https://clinicaltrials.gov/study/NCT05379985             RECRUITING   \n",
       "30304   https://clinicaltrials.gov/study/NCT05169567  ACTIVE_NOT_RECRUITING   \n",
       "33651   https://clinicaltrials.gov/study/NCT04070443  ACTIVE_NOT_RECRUITING   \n",
       "35339   https://clinicaltrials.gov/study/NCT05396833             RECRUITING   \n",
       "36226   https://clinicaltrials.gov/study/NCT03497533                UNKNOWN   \n",
       "37082   https://clinicaltrials.gov/study/NCT04665206             RECRUITING   \n",
       "38509   https://clinicaltrials.gov/study/NCT03675893             RECRUITING   \n",
       "40097   https://clinicaltrials.gov/study/NCT03574168                UNKNOWN   \n",
       "40848   https://clinicaltrials.gov/study/NCT04497116  ACTIVE_NOT_RECRUITING   \n",
       "40889   https://clinicaltrials.gov/study/NCT01226316  ACTIVE_NOT_RECRUITING   \n",
       "41384   https://clinicaltrials.gov/study/NCT05199168             RECRUITING   \n",
       "45008   https://clinicaltrials.gov/study/NCT05387265             RECRUITING   \n",
       "45624   https://clinicaltrials.gov/study/NCT03188965              COMPLETED   \n",
       "45894   https://clinicaltrials.gov/study/NCT04787042             RECRUITING   \n",
       "46236   https://clinicaltrials.gov/study/NCT05071053  ACTIVE_NOT_RECRUITING   \n",
       "46358   https://clinicaltrials.gov/study/NCT04170153             RECRUITING   \n",
       "48919   https://clinicaltrials.gov/study/NCT04607421             RECRUITING   \n",
       "49719   https://clinicaltrials.gov/study/NCT03155061  ACTIVE_NOT_RECRUITING   \n",
       "52182   https://clinicaltrials.gov/study/NCT03787953                UNKNOWN   \n",
       "52296   https://clinicaltrials.gov/study/NCT04972110             RECRUITING   \n",
       "52616   https://clinicaltrials.gov/study/NCT04928846             RECRUITING   \n",
       "54647   https://clinicaltrials.gov/study/NCT01028495              COMPLETED   \n",
       "56462   https://clinicaltrials.gov/study/NCT03412994                UNKNOWN   \n",
       "59633   https://clinicaltrials.gov/study/NCT05166577             RECRUITING   \n",
       "60402   https://clinicaltrials.gov/study/NCT04405778             RECRUITING   \n",
       "60620   https://clinicaltrials.gov/study/NCT03313778  ACTIVE_NOT_RECRUITING   \n",
       "61011   https://clinicaltrials.gov/study/NCT05006794             RECRUITING   \n",
       "65382   https://clinicaltrials.gov/study/NCT05687266             RECRUITING   \n",
       "66569   https://clinicaltrials.gov/study/NCT03585725             TERMINATED   \n",
       "68631   https://clinicaltrials.gov/study/NCT03519230  ACTIVE_NOT_RECRUITING   \n",
       "70405   https://clinicaltrials.gov/study/NCT05198934  ACTIVE_NOT_RECRUITING   \n",
       "71607   https://clinicaltrials.gov/study/NCT03631784  ACTIVE_NOT_RECRUITING   \n",
       "72052   https://clinicaltrials.gov/study/NCT02089334             TERMINATED   \n",
       "72434   https://clinicaltrials.gov/study/NCT05094336             RECRUITING   \n",
       "73090   https://clinicaltrials.gov/study/NCT04092673             RECRUITING   \n",
       "75749   https://clinicaltrials.gov/study/NCT05029882             RECRUITING   \n",
       "76276   https://clinicaltrials.gov/study/NCT03838159  ACTIVE_NOT_RECRUITING   \n",
       "82781   https://clinicaltrials.gov/study/NCT03709680             RECRUITING   \n",
       "83712   https://clinicaltrials.gov/study/NCT03752398             RECRUITING   \n",
       "88829   https://clinicaltrials.gov/study/NCT04794699             RECRUITING   \n",
       "89979   https://clinicaltrials.gov/study/NCT03139370             TERMINATED   \n",
       "90702   https://clinicaltrials.gov/study/NCT04009681             RECRUITING   \n",
       "95478   https://clinicaltrials.gov/study/NCT04991480             RECRUITING   \n",
       "99057   https://clinicaltrials.gov/study/NCT03875235  ACTIVE_NOT_RECRUITING   \n",
       "100156  https://clinicaltrials.gov/study/NCT03526835             RECRUITING   \n",
       "100250  https://clinicaltrials.gov/study/NCT04933669             RECRUITING   \n",
       "100563  https://clinicaltrials.gov/study/NCT03543813  ACTIVE_NOT_RECRUITING   \n",
       "101289  https://clinicaltrials.gov/study/NCT04485013  ACTIVE_NOT_RECRUITING   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "937     This is a first-in-human, Phase 1/2 open-label...            NO   \n",
       "2871    A phase 3 study to demonstrate whether lorlati...           YES   \n",
       "4940    Primary Objective:\\n\\n-To determine the antitu...            NO   \n",
       "6913    This clinical trial is evaluating a drug calle...            NO   \n",
       "10479   This study examines the correlation between AT...            NO   \n",
       "13464   The purpose of the study is to test how well p...            NO   \n",
       "14419   The primary objective of this study is to asse...            NO   \n",
       "15178   It has been reported that radiation therapy fo...            NO   \n",
       "16549   To assess the safety and efficacy of galinpepi...            NO   \n",
       "17927   This is a phase I, clinical research study of ...            NO   \n",
       "20300   The overall objective of this proposal is to d...            NO   \n",
       "24891   Evaluate the safety and tolerability of RMC-62...            NO   \n",
       "30304   This study will evaluate the effect of adding ...            NO   \n",
       "33651   The investigators hypothesize that, in newly d...            NO   \n",
       "35339   This is an open-label, multicenter, clinical s...            NO   \n",
       "36226   This is a single arm, open-label, single-cente...            NO   \n",
       "37082   This is an open-label, dose escalation and exp...            NO   \n",
       "38509   This research study is studying a combination ...            NO   \n",
       "40097   This is a single center, single arm, open-labl...            NO   \n",
       "40848   The primary purpose of this study is to define...            NO   \n",
       "40889   This study is designed to investigate the safe...            NO   \n",
       "41384   The clinical value of intraoperative nerve mon...            NO   \n",
       "45008   The purpose of this first-in-human study, CTMX...            NO   \n",
       "45624   The ATR (ataxia-telangiectasia and Rad3 relate...            NO   \n",
       "45894   This is a multiphase, multicenter study, which...            NO   \n",
       "46236   Primary Objectives:\\n\\nPart 1: to confirm the ...            NO   \n",
       "46358   This is an open-label, Phase I, first-in-human...            NO   \n",
       "48919   The purpose of this study is to evaluate two s...            NO   \n",
       "49719   The objective of the study is to evaluate the ...            NO   \n",
       "52182   The study was designed to analyze the efficacy...            NO   \n",
       "52296   The primary purpose of this study is to assess...            NO   \n",
       "52616   Cancer is a condition where cells in a specifi...            NO   \n",
       "54647   To assess the safety and efficacy of a combine...            NO   \n",
       "56462   (1) Evaluate the efficacy of apatinib in combi...            NO   \n",
       "59633   This study will evaluate the safety and effica...            NO   \n",
       "60402   Some solid tumors make a lot of a protein call...            NO   \n",
       "60620   The purpose of this study is to assess the saf...            NO   \n",
       "61011   This is a Phase I open-label, multi-center stu...            NO   \n",
       "65382   This is a Phase III, randomized, open-label, m...            NO   \n",
       "66569   This is a A Pilot Investigator-Initiated Study...            NO   \n",
       "68631   To evaluate the efficacy, safety and tolerabil...            NO   \n",
       "70405   The aim of the study is to compare progression...            NO   \n",
       "71607   This is a trial in adult participants with unr...           YES   \n",
       "72052   The purpose of this study is to determine the ...           YES   \n",
       "72434   The primary objective of Parts 1 and 2 of this...            NO   \n",
       "73090   This clinical trial is a Phase 1-2, open-label...            NO   \n",
       "75749   Cancer is a condition where cells in a specifi...            NO   \n",
       "76276   This is an open-label, randomised, two-arm, ph...            NO   \n",
       "82781   A study to learn about safety and find out max...            NO   \n",
       "83712   This is a Phase 1, multiple dose, ascending do...            NO   \n",
       "88829   This is a Phase 1, open-label, multicenter, do...            NO   \n",
       "89979   The primary objectives of Phase 1A are to eval...            NO   \n",
       "90702   Primary Objectives:\\n\\n* Evaluate the safety a...            NO   \n",
       "95478   This clinical trial is evaluating a drug calle...            NO   \n",
       "99057   Durvalumab or Placebo in Combination With Gemc...           YES   \n",
       "100156  This is a Phase 1/2 open-label, multi-center, ...            NO   \n",
       "100250  The R0 resection rate of gastrointestinal stro...            NO   \n",
       "100563  The purpose of this first-in-human study of CX...            NO   \n",
       "101289  TTX-080-001 is a Phase 1, open label, dose esc...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "937     Solid Tumor, Adult|Brain Tumor, Primary|Desmop...   \n",
       "2871                       Carcinoma, Non-Small-Cell Lung   \n",
       "4940    Malignant Melanoma|Squamous Cell Carcinoma of ...   \n",
       "6913    Advanced Cancer|Metastatic Cancer|Ovarian Canc...   \n",
       "10479                     Solid Tumor, Unspecified, Adult   \n",
       "13464   Advanced Solid Tumors (Excluding Prostate Canc...   \n",
       "14419                            Metastatic Breast Cancer   \n",
       "15178                                    Low-grade Glioma   \n",
       "16549                              Acute Myeloid Leukemia   \n",
       "17927                                     Prostate Cancer   \n",
       "20300                                         Lung Cancer   \n",
       "24891   Non-small Cell Lung Cancer (NSCLC)|Colorectal ...   \n",
       "30304                 Breast Neoplasm|Neoplasm Metastasis   \n",
       "33651   Philadelphia Chromosome Positive CML|BCR-ABL P...   \n",
       "35339   Metastatic or Locally Advanced Unresectable So...   \n",
       "36226                         Non-hodgkin Lymphoma,B Cell   \n",
       "37082                     Solid Tumor, Adult|Mesothelioma   \n",
       "38509                                  Endometrial Cancer   \n",
       "40097                 B-cell Acute Lymphoblastic Leukemia   \n",
       "40848                                Advanced Solid Tumor   \n",
       "40889   Advanced Solid Malignancy|Safety and Tolerabil...   \n",
       "41384                                   Esophageal Cancer   \n",
       "45008                                        Solid Tumors   \n",
       "45624   Advanced Solid Tumor|Non-Hodgkin's Lymphoma|Ma...   \n",
       "45894   Cancer|Solid Tumor|Melanoma|Renal Cell Carcino...   \n",
       "46236     Adenocarcinoma Gastric|Gastrooesophageal Cancer   \n",
       "46358   Metastatic or Locally Advanced Unresectable So...   \n",
       "48919                                           Neoplasms   \n",
       "49719                 Advanced or Metastatic Solid Tumors   \n",
       "52182                               Advanced Solid Tumors   \n",
       "52296                         Advanced Solid Tumor, Adult   \n",
       "52616                          Non Small Cell Lung Cancer   \n",
       "54647                        Metastatic Pancreatic Cancer   \n",
       "56462                                Colorectal Neoplasms   \n",
       "59633   Nasopharyngeal Carcinoma|EBV-Related Gastric C...   \n",
       "60402                                        Solid Tumors   \n",
       "60620                                        Solid Tumors   \n",
       "61011                                  Solid Malignancies   \n",
       "65382                                               NSCLC   \n",
       "66569            Follicular Lymphoma|Mantle Cell Lymphoma   \n",
       "68631                                      Ovarian Cancer   \n",
       "70405                             Colorectal Cancer (CRC)   \n",
       "71607                          Non-small Cell Lung Cancer   \n",
       "72052                        Metastatic Renal Cell Cancer   \n",
       "72434                     Advanced MTAP-null Solid Tumors   \n",
       "73090                                  Solid Tumor, Adult   \n",
       "75749   Non-Small Cell Lung Cancer|Advanced Solid Tumo...   \n",
       "76276                          Non Small Cell Lung Cancer   \n",
       "82781   Ewing Sarcoma|Solid Tumors|Rhabdoid Tumor|Rhab...   \n",
       "83712   Melanoma (Excluding Uveal Melanoma)|Cervical C...   \n",
       "88829                                         Solid Tumor   \n",
       "89979                                         Solid Tumor   \n",
       "90702                                          Metastasis   \n",
       "95478     Advanced Cancer|Metastatic Cancer|Breast Cancer   \n",
       "99057                             Biliary Tract Neoplasms   \n",
       "100156  Advanced/Metastatic Solid Tumors|Colorectal Ca...   \n",
       "100250  Progression-free Survival|Gastrointestinal Str...   \n",
       "100563  Solid Tumor, Adult|Head and Neck Cancer|Non Sm...   \n",
       "101289                                             Cancer   \n",
       "\n",
       "                                            Interventions  \\\n",
       "937                                         DRUG: PBI-200   \n",
       "2871                    DRUG: Lorlatinib|DRUG: Crizotinib   \n",
       "4940                      DRUG: THOR-707|DRUG: Cemiplimab   \n",
       "6913     DRUG: ART0380|DRUG: Gemcitabine|DRUG: Irinotecan   \n",
       "10479      OTHER: Determination of ATM alteration status.   \n",
       "13464      DRUG: Elimusertib (BAY1895344)|DRUG: Niraparib   \n",
       "14419   DRUG: Sacituzumab Govitecan-hziy|DRUG: Eribuli...   \n",
       "15178   DRUG: Temozolomide|RADIATION: intensity modula...   \n",
       "16549   BIOLOGICAL: Galinpepimut-S|DRUG: Azacitidine|D...   \n",
       "17927   DRUG: EPI-7386 (QD)|DRUG: EPI-7386 (BID)|DRUG:...   \n",
       "20300      DEVICE: Biophotonic platform for VOC detection   \n",
       "24891                                      DRUG: RMC-6236   \n",
       "30304   DRUG: Abemaciclib|DRUG: Fulvestrant|DRUG: Placebo   \n",
       "33651                      DRUG: Ponatinib|DRUG: Imatinib   \n",
       "35339              DRUG: M1774|DRUG: M4076|DRUG: Avelumab   \n",
       "36226                           BIOLOGICAL: TriCAR-T-CD19   \n",
       "37082                                        DRUG: VT3989   \n",
       "38509   DRUG: Letrozole|DRUG: Abemaciclib|DRUG: LY3023...   \n",
       "40097                        BIOLOGICAL: CD19-CAR-T Cells   \n",
       "40848   DRUG: RP-3500 (camonsertib)|DRUG: Talazoparib|...   \n",
       "40889   DRUG: AZD5363|DRUG: AZD5363|DRUG: AZD5363|DRUG...   \n",
       "41384          PROCEDURE: intraoperative nerve monitoring   \n",
       "45008                                        DRUG: CX-904   \n",
       "45624                      DRUG: Elimusertib (BAY1895344)   \n",
       "45894   BIOLOGICAL: ST-067|BIOLOGICAL: Obinutuzumab 25...   \n",
       "46236   DRUG: Ramucirumab (CYRAMZAÂ®)|DRUG: Tusamitamab...   \n",
       "46358                         DRUG: M1774|DRUG: Niraparib   \n",
       "48919   DRUG: Encorafenib|DRUG: Cetuximab|DRUG: Oxalip...   \n",
       "49719                       DRUG: ONO-4578|DRUG: ONO-4538   \n",
       "52182                    DRUG: Anti-PD-1/PD-L1 antibodies   \n",
       "52296                         DRUG: RP-3500 (camonsertib)   \n",
       "52616   BIOLOGICAL: Telisotuzumab Vedotin|DRUG: Docetaxel   \n",
       "54647                      DRUG: RX-0201 plus Gemcitabine   \n",
       "56462   DRUG: Apatinib|DRUG: standard second-line chem...   \n",
       "59633   DRUG: Nanatinostat|DRUG: Nanatinostat|DRUG: Va...   \n",
       "60402                                 BIOLOGICAL: TAK-102   \n",
       "60620     BIOLOGICAL: mRNA-4157|BIOLOGICAL: Pembrolizumab   \n",
       "61011   DRUG: GS-9716|DRUG: Docetaxel|DRUG: sacituzuma...   \n",
       "65382   DRUG: Datopotamab deruxtecan|DRUG: Durvalumab|...   \n",
       "66569                                     DRUG: Ribavirin   \n",
       "68631       DRUG: Pamiparib capsule|DRUG: Placebo capsule   \n",
       "70405   DRUG: Sotorasib|DRUG: Panitumumab|DRUG: Triflu...   \n",
       "71607   DRUG: Pembrolizumab 200 mg|DRUG: Paclitaxel 45...   \n",
       "72052                                       DRUG: RX-0201   \n",
       "72434   DRUG: AMG 193|DRUG: Docetaxel|DRUG: Comparator...   \n",
       "73090   DRUG: eFT226|DRUG: Sotorasib|DRUG: Fulvestrant...   \n",
       "75749                                      DRUG: ABBV-400   \n",
       "76276   DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Nivol...   \n",
       "82781   DRUG: Palbociclib|DRUG: Temozolomide|DRUG: Iri...   \n",
       "83712   BIOLOGICAL: XmAbÂ®23104|BIOLOGICAL: YervoyÂ® (ip...   \n",
       "88829       DRUG: IDE397|DRUG: Docetaxel|DRUG: Paclitaxel   \n",
       "89979   DRUG: KITE-718|DRUG: Cyclophosphamide|DRUG: Fl...   \n",
       "90702   DRUG: THOR-707|DRUG: Checkpoint inhibitor|DRUG...   \n",
       "95478     DRUG: ART4215|DRUG: Talazoparib|DRUG: Niraparib   \n",
       "99057                      DRUG: Durvalumab|DRUG: Placebo   \n",
       "100156                                     DRUG: MCLA-158   \n",
       "100250                                     DRUG: Imatinib   \n",
       "100563                                      DRUG: CX-2029   \n",
       "101289  DRUG: TTX-080|DRUG: TTX-080|DRUG: pembrolizuma...   \n",
       "\n",
       "                                                  Sponsor  \\\n",
       "937                                   Pyramid Biosciences   \n",
       "2871                                               Pfizer   \n",
       "4940                                               Sanofi   \n",
       "6913                                    Artios Pharma Ltd   \n",
       "10479                                   Artios Pharma Ltd   \n",
       "13464                                               Bayer   \n",
       "14419                                     Gilead Sciences   \n",
       "15178                                 West China Hospital   \n",
       "16549                          Sellas Life Sciences Group   \n",
       "17927                                ESSA Pharmaceuticals   \n",
       "20300             National University Hospital, Singapore   \n",
       "24891                          Revolution Medicines, Inc.   \n",
       "30304                               Eli Lilly and Company   \n",
       "33651                                  Centre Leon Berard   \n",
       "35339   EMD Serono Research & Development Institute, Inc.   \n",
       "36226                                Timmune Biotech Inc.   \n",
       "37082                            Vivace Therapeutics, Inc   \n",
       "38509                        Dana-Farber Cancer Institute   \n",
       "40097                       Bioceltech Therapeutics, Ltd.   \n",
       "40848                                 Repare Therapeutics   \n",
       "40889                                         AstraZeneca   \n",
       "41384   Tianjin Medical University Cancer Institute an...   \n",
       "45008                                 CytomX Therapeutics   \n",
       "45624                                               Bayer   \n",
       "45894                                  Simcha IL-18, Inc.   \n",
       "46236                                              Sanofi   \n",
       "46358   EMD Serono Research & Development Institute, Inc.   \n",
       "48919                                              Pfizer   \n",
       "49719                          Ono Pharmaceutical Co. Ltd   \n",
       "52182                        Chinese PLA General Hospital   \n",
       "52296                                 Repare Therapeutics   \n",
       "52616                                              AbbVie   \n",
       "54647                        Rexahn Pharmaceuticals, Inc.   \n",
       "56462                                       Liqiang Zhong   \n",
       "59633                          Viracta Therapeutics, Inc.   \n",
       "60402                                              Takeda   \n",
       "60620                                     ModernaTX, Inc.   \n",
       "61011                                     Gilead Sciences   \n",
       "65382                                         AstraZeneca   \n",
       "66569         Weill Medical College of Cornell University   \n",
       "68631                                             BeiGene   \n",
       "70405                                               Amgen   \n",
       "71607                             Merck Sharp & Dohme LLC   \n",
       "72052                        Rexahn Pharmaceuticals, Inc.   \n",
       "72434                                               Amgen   \n",
       "73090                               Effector Therapeutics   \n",
       "75749                                              AbbVie   \n",
       "76276                                      FundaciÃ³n GECP   \n",
       "82781                                              Pfizer   \n",
       "83712                                        Xencor, Inc.   \n",
       "88829                                  IDEAYA Biosciences   \n",
       "89979                              Kite, A Gilead Company   \n",
       "90702                     Synthorx, Inc, a Sanofi company   \n",
       "95478                                   Artios Pharma Ltd   \n",
       "99057                                         AstraZeneca   \n",
       "100156                                         Merus N.V.   \n",
       "100250   First Affiliated Hospital of Zhejiang University   \n",
       "100563                                CytomX Therapeutics   \n",
       "101289                           Tizona Therapeutics, Inc   \n",
       "\n",
       "                                            Collaborators     Sex  \\\n",
       "937                                                   NaN     ALL   \n",
       "2871                                                  NaN     ALL   \n",
       "4940                                                  NaN     ALL   \n",
       "6913                                                  NaN     ALL   \n",
       "10479                                                 NaN     ALL   \n",
       "13464                                     GlaxoSmithKline     ALL   \n",
       "14419                                                 NaN     ALL   \n",
       "15178                                                 NaN     ALL   \n",
       "16549                                                 NaN     ALL   \n",
       "17927                                                 NaN    MALE   \n",
       "20300                                                 NaN     ALL   \n",
       "24891                                                 NaN     ALL   \n",
       "30304                                                 NaN     ALL   \n",
       "33651                                                 NaN     ALL   \n",
       "35339                      Merck KGaA, Darmstadt, Germany     ALL   \n",
       "36226                  Hunan Provincial People's Hospital     ALL   \n",
       "37082                                                 NaN     ALL   \n",
       "38509                               Eli Lilly and Company  FEMALE   \n",
       "40097                                                 NaN     ALL   \n",
       "40848                                     Roche Pharma AG     ALL   \n",
       "40889                                                 NaN     ALL   \n",
       "41384                                                 NaN     ALL   \n",
       "45008                                                 NaN     ALL   \n",
       "45624                                                 NaN     ALL   \n",
       "45894                             Merck Sharp & Dohme LLC     ALL   \n",
       "46236                                                 NaN     ALL   \n",
       "46358                      Merck KGaA, Darmstadt, Germany     ALL   \n",
       "48919   Ono Pharmaceutical Co. Ltd|Merck KGaA, Darmsta...     ALL   \n",
       "49719                                                 NaN     ALL   \n",
       "52182               LinkDoc Technology (Beijing) Co. Ltd.     ALL   \n",
       "52296                                     Roche Pharma AG     ALL   \n",
       "52616                                                 NaN     ALL   \n",
       "54647                                                 NaN     ALL   \n",
       "56462                                                 NaN     ALL   \n",
       "59633                                                 NaN     ALL   \n",
       "60402                                                 NaN     ALL   \n",
       "60620                             Merck Sharp & Dohme LLC     ALL   \n",
       "61011                                                 NaN     ALL   \n",
       "65382                                                 NaN     ALL   \n",
       "66569              Memorial Sloan Kettering Cancer Center     ALL   \n",
       "68631                                                 NaN  FEMALE   \n",
       "70405                                                 NaN     ALL   \n",
       "71607                                                 NaN     ALL   \n",
       "72052                                                 NaN     ALL   \n",
       "72434                                                 NaN     ALL   \n",
       "73090                                                 NaN     ALL   \n",
       "75749                                                 NaN     ALL   \n",
       "76276                                                 NaN     ALL   \n",
       "82781                     Children's Oncology Group (COG)     ALL   \n",
       "83712                                            ICON plc     ALL   \n",
       "88829                                                 NaN     ALL   \n",
       "89979                                                 NaN     ALL   \n",
       "90702                                                 NaN     ALL   \n",
       "95478                                                 NaN     ALL   \n",
       "99057                                                 NaN     ALL   \n",
       "100156                                                NaN     ALL   \n",
       "100250  Second Affiliated Hospital, School of Medicine...     ALL   \n",
       "100563                                                NaN     ALL   \n",
       "101289                                                NaN     ALL   \n",
       "\n",
       "                              Age      Study Type  \\\n",
       "937            ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "2871           ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "4940           ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "6913           ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "10479          ADULT, OLDER_ADULT   OBSERVATIONAL   \n",
       "13464          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "14419          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "15178          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "16549          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "17927          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "20300          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "24891          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "30304          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "33651          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "35339          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "36226          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "37082          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "38509          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "40097   CHILD, ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "40848          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "40889          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "41384          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "45008          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "45624          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "45894          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "46236          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "46358          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "48919   CHILD, ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "49719          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "52182          ADULT, OLDER_ADULT   OBSERVATIONAL   \n",
       "52296          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "52616          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "54647          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "56462          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "59633          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "60402          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "60620          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "61011          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "65382          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "66569          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "68631          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "70405          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "71607          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "72052          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "72434          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "73090          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "75749          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "76276          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "82781                CHILD, ADULT  INTERVENTIONAL   \n",
       "83712          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "88829          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "89979          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "90702          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "95478          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "99057          ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "100156         ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "100250         ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "100563         ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "101289         ADULT, OLDER_ADULT  INTERVENTIONAL   \n",
       "\n",
       "                                          Other IDs  \\\n",
       "937                                     PBI-200-101   \n",
       "2871                        B7461006|2016-003315-35   \n",
       "4940        ACT16845|U1111-1254-0189|2020-005332-30   \n",
       "6913                                    ART0380C001   \n",
       "10479                                   ART0380C002   \n",
       "13464                          18595|2018-003930-34   \n",
       "14419                    IMMU-132-09|2018-004201-33   \n",
       "15178                              ChiCTR1800015199   \n",
       "16549                                    SLSG18-301   \n",
       "17927                               EPI-7386-CS-001   \n",
       "20300                               SERC/1121480001   \n",
       "24891                                  RMC-6236-001   \n",
       "30304              18238|I3Y-MC-JPEF|2021-002301-10   \n",
       "33651                             ET18000120 (TIPI)   \n",
       "35339               MS201924_0020|2022-500287-35-00   \n",
       "36226                              ChiCTR1800014528   \n",
       "37082                                    VT3989-001   \n",
       "38509                                        18-301   \n",
       "40097                BT-ALL-001-v2|ChiCTR1800016541   \n",
       "40848                     RP-3500-01|2020-000301-87   \n",
       "40889    D3610C00001|EudraCT number: 2010-022167-35   \n",
       "41384                                     E20210023   \n",
       "45008                                  CTMX-904-101   \n",
       "45624                          18594|2016-004484-39   \n",
       "45894                        ST-067-001|KEYNOTE-E64   \n",
       "46236       ACT16444|U1111-1266-5040|2021-001967-26   \n",
       "46358                  MS201924_0001|2019-002203-18   \n",
       "48919            C4221015|2020-001288-99|BREAKWATER   \n",
       "49719                                   ONO-4578-01   \n",
       "52182                               PDL1-2018-301BJ   \n",
       "52296                                    RP-3500-03   \n",
       "52616                        M18-868|2021-001811-94   \n",
       "54647                               RX-0201-P2-A-07   \n",
       "56462                              ChiCTR1800014478   \n",
       "59633                                    VT3996-301   \n",
       "60402   TAK-102-1501|U1111-1247-6429|jRCT1080225204   \n",
       "60620                                mRNA-4157-P101   \n",
       "61011                                GS-US-467-5643   \n",
       "65382                    D926NC00001|2021-004606-21   \n",
       "66569                                    1709018594   \n",
       "68631      BGB-290-302|ChiCTR1800014643|CTR20171666   \n",
       "70405                                      20190172   \n",
       "71607           3475-799|MK-3475-799|2018-000714-37   \n",
       "72052                               RX-0201-P2-A-09   \n",
       "72434                                      20210023   \n",
       "73090                                   eFT226-0002   \n",
       "75749                        M21-404|2021-002258-98   \n",
       "76276            GECP 18/02_NADIM II|2018-004515-45   \n",
       "82781                       A5481092|2021-003444-25   \n",
       "83712                           XmAb23104-01|DUET-3   \n",
       "88829                                    IDE397-001   \n",
       "89979                   KITE-718-301|2020-005456-37   \n",
       "90702                       THOR-707-101 (TCD16843)   \n",
       "95478                                   ART4215C001   \n",
       "99057                    D933AC00001|2018-004688-30   \n",
       "100156                 MCLA-158-CL01|2017-004745-24   \n",
       "100250                              IIT20210023C-R1   \n",
       "100563                              CTMX-M-2029-001   \n",
       "101289                                  TTX-080-001   \n",
       "\n",
       "       Study_id_Guardant_Infinity  \\\n",
       "937                   PBI-200-101   \n",
       "2871                     B7461006   \n",
       "4940                     ACT16845   \n",
       "6913                  ART0380C001   \n",
       "10479                 ART0380C002   \n",
       "13464                       18595   \n",
       "14419                 IMMU-132-09   \n",
       "15178                       80001   \n",
       "16549                      18-301   \n",
       "17927             EPI-7386-CS-001   \n",
       "20300                       80001   \n",
       "24891                RMC-6236-001   \n",
       "30304                 I3Y-MC-JPEF   \n",
       "33651                       80001   \n",
       "35339               MS201924_0020   \n",
       "36226                       80001   \n",
       "37082                  VT3989-001   \n",
       "38509                      18-301   \n",
       "40097                       80001   \n",
       "40848                  RP-3500-01   \n",
       "40889                 D3610C00001   \n",
       "41384                    20210023   \n",
       "45008                CTMX-904-101   \n",
       "45624                       18594   \n",
       "45894                  ST-067-001   \n",
       "46236                    ACT16444   \n",
       "46358               MS201924_0001   \n",
       "48919                    C4221015   \n",
       "49719                 ONO-4578-01   \n",
       "52182                      18-301   \n",
       "52296                  RP-3500-03   \n",
       "52616                     M18-868   \n",
       "54647                      201-P2   \n",
       "56462                       80001   \n",
       "59633                  VT3996-301   \n",
       "60402                TAK-102-1501   \n",
       "60620              mRNA-4157-P101   \n",
       "61011              GS-US-467-5643   \n",
       "65382                 D926NC00001   \n",
       "66569                       18594   \n",
       "68631                       80001   \n",
       "70405                    20190172   \n",
       "71607                 MK-3475-799   \n",
       "72052                      201-P2   \n",
       "72434                    20210023   \n",
       "73090                 eFT226-0002   \n",
       "75749                     M21-404   \n",
       "76276                    NADIM II   \n",
       "82781                    A5481092   \n",
       "83712                XmAb23104-01   \n",
       "88829                  IDE397-001   \n",
       "89979                      18-301   \n",
       "90702                THOR-707-101   \n",
       "95478                 ART4215C001   \n",
       "99057                 D933AC00001   \n",
       "100156              MCLA-158-CL01   \n",
       "100250                   20210023   \n",
       "100563                   2029-001   \n",
       "101289                TTX-080-001   \n",
       "\n",
       "                             Cancertype_Guardant_Infinity  \n",
       "937                                                     -  \n",
       "2871                                          Lung Cancer  \n",
       "4940                                                    -  \n",
       "6913                                                    -  \n",
       "10479                                                   -  \n",
       "13464                                                      \n",
       "14419                                                   -  \n",
       "15178                                                      \n",
       "16549                            Endometrial Carcinoma, -  \n",
       "17927                                            Prostate  \n",
       "20300                                                      \n",
       "24891                                                   -  \n",
       "30304                                                   -  \n",
       "33651                                                      \n",
       "35339                                                   -  \n",
       "36226                                                      \n",
       "37082                                                   -  \n",
       "38509                            Endometrial Carcinoma, -  \n",
       "40097                                                      \n",
       "40848                                                   -  \n",
       "40889                                      Breast , mCRPC  \n",
       "41384                                                      \n",
       "45008                                                   -  \n",
       "45624                                                      \n",
       "45894                                                   -  \n",
       "46236                                                   -  \n",
       "46358                                                   -  \n",
       "48919                                                   -  \n",
       "49719                                                   -  \n",
       "52182                            Endometrial Carcinoma, -  \n",
       "52296                                                   -  \n",
       "52616                                                   -  \n",
       "54647                       Extranodal NK/T-cell lymphoma  \n",
       "56462                                                      \n",
       "59633                               NPC-Undifferentiated   \n",
       "60402   Liposarcoma, HepatoCellular Carcinoma, Gastric...  \n",
       "60620                                                   -  \n",
       "61011   -, Colon, Rectal, NSCLC, Colorectal, Uterine â€“...  \n",
       "65382                                                   -  \n",
       "66569                                                      \n",
       "68631                                                      \n",
       "70405                                                      \n",
       "71607                                                   -  \n",
       "72052                       Extranodal NK/T-cell lymphoma  \n",
       "72434                                                      \n",
       "73090                                      Breast, BREAST  \n",
       "75749   -, Acral melanoma, CRC, Bladder Cancer, TNBC, ...  \n",
       "76276      Adenocarcinoma, Squamous, NOS/Undifferentiated  \n",
       "82781                                                   -  \n",
       "83712                                                   -  \n",
       "88829   -, Head and Neck, Melanoma, Pancreas, Cholangi...  \n",
       "89979                            Endometrial Carcinoma, -  \n",
       "90702                                                   -  \n",
       "95478                                                   -  \n",
       "99057                                                   -  \n",
       "100156                                Gastric, HNSCC, GEA  \n",
       "100250                                                     \n",
       "100563                                                  -  \n",
       "101289                                         CRC, HNSCC  "
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clinical_trial  = clinical_trial.rename(columns = {'Study_ID':'Study_id_Guardant_Infinity','Cancertype':'Cancertype_Guardant_Infinity'})\n",
    "clinical_trial[~clinical_trial['Study_id_Guardant_Infinity'].isna()].to_csv('/ghess/pharma/scratch/gyalamanchili/clinical_trial_data_leverage/Infinity_data_clinical_trial_integration.csv',index = None)\n",
    "clinical_trial[~clinical_trial['Study_id_Guardant_Infinity'].isna()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b4fa56bd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0e76de4a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7ec18b96",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
